The news is by your side.


Anti-diabetes drug also ‘lessens kidney, heart disease’ risk

WASHINGTON: An anti-diabetic drug that lowers blood sugar levels for type 2 diabetes sufferers also significantly cuts the risk of cardiovascular and kidney disease, according to a study published Monday. The findings, published in the New England Journal of Medicine, came in a clinical trial of more than 10,000 patients in 30 countries, using canagliflozin. It found the drug reduced the overall risk of cardiovascular disease by 14 percent and reduced the risk of heart failure hospitalization by 33 percent. It was also…